These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21225354)

  • 1. Alternative therapy used as primary treatment for breast cancer negatively impacts outcomes.
    Han E; Johnson N; DelaMelena T; Glissmeyer M; Steinbock K
    Ann Surg Oncol; 2011 Apr; 18(4):912-6. PubMed ID: 21225354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
    Wyatt G; Sikorskii A; Wills CE; Su H
    Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of breast cancer in patients who use alternative therapies as primary treatment.
    Chang EY; Glissmeyer M; Tonnes S; Hudson T; Johnson N
    Am J Surg; 2006 Oct; 192(4):471-3. PubMed ID: 16978951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer.
    Adler SR; Fosket JR
    J Fam Pract; 1999 Jun; 48(6):453-8. PubMed ID: 10386489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia.
    Oh B; Butow P; Mullan B; Beale P; Pavlakis N; Rosenthal D; Clarke S
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):342-9. PubMed ID: 21114784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
    Pedersen CG; Christensen S; Jensen AB; Zachariae R
    Eur J Cancer; 2009 Dec; 45(18):3172-81. PubMed ID: 19811905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden.
    Hietala M; Henningson M; Ingvar C; Jönsson PE; Rose C; Jernström H
    Acta Oncol; 2011 Jan; 50(1):134-43. PubMed ID: 20500030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.
    Dy GK; Bekele L; Hanson LJ; Furth A; Mandrekar S; Sloan JA; Adjei AA
    J Clin Oncol; 2004 Dec; 22(23):4810-5. PubMed ID: 15570083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
    Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
    Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of alternative medicine by women with early-stage breast cancer.
    Burstein HJ; Gelber S; Guadagnoli E; Weeks JC
    N Engl J Med; 1999 Jun; 340(22):1733-9. PubMed ID: 10352166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of complementary and alternative medicine in patients with cancer: a UK survey.
    Scott JA; Kearney N; Hummerston S; Molassiotis A
    Eur J Oncol Nurs; 2005 Jun; 9(2):131-7. PubMed ID: 15944106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A test of the self-help model and use of complementary and alternative medicine among Hispanic women during treatment for breast cancer.
    Owens B
    Oncol Nurs Forum; 2007 Jul; 34(4):E42-50. PubMed ID: 17723972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of complementary and alternative medicine among cancer patients in Israel.
    Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
    Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
    Rakovitch E; Pignol JP; Chartier C; Ezer M; Verma S; Dranitsaris G; Clemons M
    Breast Cancer Res Treat; 2005 Mar; 90(2):139-48. PubMed ID: 15803360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians.
    Ashikaga T; Bosompra K; O'Brien P; Nelson L
    Support Care Cancer; 2002 Oct; 10(7):542-8. PubMed ID: 12324809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of complementary and alternative medicine among Malay breast cancer survivors.
    Shaharudin SH; Sulaiman S; Emran NA; Shahril MR; Hussain SN
    Altern Ther Health Med; 2011; 17(1):50-6. PubMed ID: 21614944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of complementary therapies by Australian women with breast cancer.
    Kremser T; Evans A; Moore A; Luxford K; Begbie S; Bensoussan A; Marigliani R; Zorbas H
    Breast; 2008 Aug; 17(4):387-94. PubMed ID: 18534852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.